hg_115293.1

Basic information about the TSS

---

TSS ID: hg_115293.1 Species: human Chr: chr11		Start: 66231841 End: 66231849 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000528935.1 Distance: -48 GeneID: 55690 HGNC/MGI_ID: HGNC:30032 UniProt_ID: E9PNZ9

Gene_name: phosphofurin acidic cluster sorting protein 1 Gene_symbol: PACS1 Gene_synonyms: FLJ10209 KIAA1175 Gene_source: HGNC:30032

TATA-Box annotation

---

Distance to TSS:	-25449
Nearest PromoterID:	NM_001134775
Entrez ID:	64837
Nearest Unigene:	Hs.280792
Nearest Refseq:	NM_022822
Nearest Ensembl:	ENSG00000174996
Gene Name:	phosphofurin acidic cluster sorting protein 1
Gene Alias:	-
Gene Description:	kinesin light chain 2
Gene Type:	protein-coding
CpG%:	0.035
GC%:	0.606965
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PACS1 p2@PACS1 p3@PACS1 p4@PACS1 p5@PACS1 p7@PACS1
Sample		p1@PACS1	p2@PACS1	p3@PACS1	p4@PACS1	p5@PACS1	p7@PACS1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.92	1.95	0.97	0.58	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	16.99	2.83	0.81	0.61	0.20	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	17.55	3.67	0.77	0.58	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.51	4.78	0.62	1.04	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	15.07	1.35	1.80	0.45	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	13.37	2.91	1.16	0.19	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	20.05	3.05	0.65	0.65	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	18.17	2.66	0.73	1.21	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.30	4.27	1.50	0.00	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.07	0.58	0.58	1.16	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.98	1.21	2.43	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.86	3.66	2.85	0.41	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	82.85	2.26	0.16	0.81	1.45	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	60.29	1.95	0.15	1.50	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	80.58	1.54	0.66	0.88	0.88	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	62.87	1.51	0.25	0.50	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	53.95	1.31	0.22	1.09	0.22	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	56.10	0.00	0.84	0.42	1.27	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	46.38	1.60	0.53	0.00	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	52.80	2.26	0.60	0.75	0.00	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	62.42	1.07	0.53	1.07	1.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	51.27	0.86	0.69	1.04	1.04	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	55.71	1.55	0.65	1.55	0.65	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	53.63	2.43	0.49	2.18	0.49	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	64.24	1.29	0.77	1.03	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	60.77	1.27	0.00	0.63	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	47.25	1.10	0.00	1.10	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	61.77	2.59	0.24	0.94	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	49.43	0.97	0.32	0.65	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	56.64	2.17	0.36	0.72	0.72	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	54.22	0.84	0.00	0.84	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	51.97	1.37	0.20	1.37	0.59	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	41.15	1.48	0.21	0.21	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.40	1.15	0.16	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	54.04	2.06	0.56	0.75	0.93	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	61.32	1.72	0.77	0.77	0.19	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	53.34	1.02	1.23	0.82	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	55.81	1.01	0.81	1.01	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	58.88	1.89	0.27	0.81	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	56.65	2.16	0.48	0.48	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	54.11	2.12	0.71	0.94	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	32.21	1.02	0.44	0.73	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	64.53	1.90	1.27	1.05	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	67.13	2.10	0.87	1.22	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	65.85	1.00	0.20	1.41	1.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	71.19	2.79	2.09	1.40	0.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	72.69	3.36	1.20	0.96	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	57.52	1.79	0.60	1.49	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	83.06	2.39	0.96	1.44	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	69.35	2.02	0.61	0.81	0.40	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	61.49	2.05	0.41	2.05	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	92.06	2.67	0.67	1.78	0.22	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	60.68	0.71	1.42	2.13	0.35	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	61.64	2.32	1.33	1.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	8.39	0.00	0.00	0.00	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	29.85	1.84	0.92	3.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	77.79	1.62	0.65	3.89	0.97	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	85.11	2.57	0.32	1.93	1.28	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	51.24	1.26	0.31	1.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	106.46	1.41	0.00	5.64	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	90.85	1.12	1.12	5.05	1.68	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	62.10	0.00	0.80	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	64.56	1.36	1.02	1.02	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	109.82	1.95	0.32	6.17	2.27	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	112.17	1.42	1.42	1.06	0.71	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	99.45	0.98	0.98	0.49	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	79.34	1.49	0.00	1.49	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	71.77	0.47	0.94	2.35	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	50.01	1.32	0.66	1.32	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	67.13	2.78	0.93	1.24	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	77.66	0.61	0.61	0.92	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	46.72	2.06	0.79	1.11	0.32	0.63
Adipocyte - breast, donor2	11327-117E4	28.72	3.37	0.48	0.32	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	42.49	2.80	0.64	1.65	0.13	0.38
Adipocyte - omental, donor2	11474-119C7	46.34	1.49	0.00	1.49	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	30.48	2.34	0.33	0.33	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	29.99	1.91	0.64	0.64	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	1.10	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.52	2.71	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.76	0.87	0.52	0.70	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	46.35	3.13	0.78	1.17	0.98	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	30.89	1.54	1.29	0.77	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	36.52	2.79	0.56	1.39	1.39	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	45.26	4.11	0.59	0.59	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	31.05	1.53	0.40	0.64	0.72	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	36.79	2.58	0.97	0.00	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	27.19	2.13	1.60	0.00	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	25.04	2.78	0.56	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	23.29	0.00	0.00	0.42	1.25	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	27.63	1.51	1.00	0.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	26.83	2.29	0.00	0.00	0.65	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	20.70	1.83	0.61	0.61	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	73.15	2.65	1.77	0.44	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	65.62	3.59	2.51	0.72	1.08	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	55.11	2.40	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	58.47	1.08	0.54	0.54	0.54	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	30.12	0.00	0.00	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	64.10	2.88	0.62	0.00	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	27.00	1.14	0.92	0.46	0.57	0.34
Anulus Pulposus Cell, donor2	11463-119B5	33.80	2.20	0.49	1.22	0.24	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	21.12	2.25	0.45	0.45	0.90	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	22.14	1.74	0.43	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.92	2.09	0.60	0.60	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	3.79	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.16	0.00	0.00	1.32	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	22.74	2.27	0.65	0.32	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	18.93	0.49	0.49	0.49	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	26.72	1.78	0.00	0.59	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.96	1.13	0.38	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	16.69	0.73	1.45	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	1.25	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.02	1.48	0.33	0.49	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	24.57	2.73	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	38.15	1.06	0.90	0.90	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	24.11	1.61	0.00	1.07	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	25.88	0.94	0.38	0.19	0.94	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	34.21	1.07	0.80	0.53	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	31.21	0.98	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	25.21	1.82	0.17	0.17	0.50	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	2.40	0.00	0.00	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	0.00	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	27.79	1.54	0.00	0.34	0.86	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.87	0.00	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	26.18	3.04	0.76	0.38	0.76	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	29.07	1.21	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.09	1.14	0.57	1.71	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	24.37	2.57	0.21	0.21	0.21	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	25.03	0.52	0.77	1.29	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	18.77	0.47	1.88	0.94	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	21.54	2.57	0.96	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.83	1.43	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.98	2.34	1.17	1.75	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	26.19	1.81	0.90	0.00	0.90	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	36.83	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	25.43	1.53	0.51	0.00	1.53	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	27.76	1.53	0.25	0.76	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.97	1.27	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	27.19	0.86	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.29	1.27	0.42	0.42	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	24.07	1.74	0.29	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	21.73	0.00	0.00	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	23.06	0.68	0.00	0.85	0.85	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	6.95	2.32	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	44.36	0.00	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	25.52	1.93	0.86	0.86	1.50	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	0.00	0.73	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	24.14	0.69	0.92	0.00	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	32.29	2.29	0.00	0.51	0.51	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	26.22	1.03	0.00	0.83	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	31.52	1.22	0.31	0.00	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.08	0.48	0.48	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	27.94	2.22	1.33	0.44	0.44	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	14.95	2.22	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	21.98	1.59	0.79	0.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.17	0.73	0.73	0.73	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	72.95	3.19	2.82	0.37	0.86	0.61
Astrocyte - cerebellum, donor2	11580-120F5	80.62	4.79	3.08	0.51	1.03	1.03
Astrocyte - cerebellum, donor3	11661-122F5	53.70	2.73	0.42	0.42	0.00	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	25.45	2.44	1.05	1.05	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	41.09	2.59	1.46	0.65	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	46.99	3.73	1.19	0.60	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	67.55	5.73	2.29	0.69	0.34	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	62.39	4.64	2.00	0.75	0.38	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.22	5.58	2.28	0.23	0.68	0.11
Basophils, donor1	12241-129G9	60.41	4.97	3.66	0.52	0.00	0.00
Basophils, donor2	12242-129H1	56.64	6.13	2.16	0.72	0.36	0.00
Basophils, donor3	12243-129H2	82.61	7.64	4.56	1.32	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	30.62	1.51	2.16	0.00	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	62.63	5.94	2.29	0.91	1.37	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	24.48	1.26	0.00	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	35.14	1.04	1.46	0.42	0.62	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	28.79	2.30	0.46	0.46	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	15.30	1.62	0.54	0.00	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	27.62	1.96	1.44	0.62	0.62	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	41.69	2.33	3.49	0.70	0.47	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.54	3.84	2.24	1.28	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	59.17	7.89	6.76	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	63.29	4.08	2.78	0.19	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	70.47	5.05	3.07	0.00	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	58.59	1.13	1.42	0.85	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	73.16	3.41	4.93	1.52	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	63.12	5.26	1.97	2.30	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	37.73	1.59	2.46	0.58	0.43	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	34.70	3.92	1.81	0.30	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	44.54	3.55	2.84	0.47	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	25.44	2.34	1.17	0.33	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	20.98	1.38	0.83	0.28	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	29.75	2.23	0.74	0.00	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	22.91	1.17	0.39	0.20	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	25.10	1.96	2.14	0.53	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.50	1.74	0.87	0.22	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	19.90	1.64	0.94	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	33.79	2.11	2.11	0.00	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	31.06	3.33	2.22	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	25.88	1.93	0.89	0.00	0.45	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	22.35	2.99	0.80	0.40	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	16.03	1.67	0.42	0.42	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	19.22	0.69	0.92	0.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	17.64	3.39	1.36	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	18.33	1.75	1.31	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	33.35	2.15	2.15	0.00	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	37.86	2.62	1.74	0.35	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	48.39	2.52	0.84	0.42	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	18.74	1.47	0.18	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	19.73	1.41	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.79	1.32	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	25.98	1.74	0.52	0.17	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	33.08	2.23	1.86	1.12	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	29.10	2.37	0.86	0.43	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.47	2.05	1.23	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	18.31	2.09	2.09	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	13.46	2.09	0.93	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	24.41	1.53	1.09	0.44	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	21.48	1.62	1.15	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	25.99	2.17	1.73	0.22	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	44.69	2.80	4.36	0.31	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	35.45	2.62	3.49	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	48.83	5.35	2.68	0.45	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	39.04	2.04	2.55	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	39.30	1.10	1.98	0.22	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	36.42	1.89	2.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	140.23	6.10	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	124.75	4.07	5.42	1.36	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	126.34	5.18	4.14	0.00	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	122.60	7.46	5.33	1.60	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	118.47	6.97	5.90	1.07	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	122.14	8.42	7.72	1.40	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	105.10	2.35	7.84	2.35	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	141.06	3.95	3.95	1.32	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	387.12	9.04	12.33	5.75	4.11	0.00
CD19+ B Cells, donor2	11624-122B4	290.90	12.33	5.08	2.90	4.35	0.00
CD19+ B Cells, donor3	11705-123B4	286.74	14.64	6.06	3.03	1.51	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.44	0.00	0.40	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.19	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	66.27	4.02	5.02	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	40.45	3.37	2.81	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	34.95	2.63	2.25	0.38	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	20.74	1.80	2.93	0.23	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	237.44	21.78	11.78	1.43	1.79	0.00
CD4+ T Cells, donor2	11306-117C1	213.10	19.60	12.25	1.84	0.61	1.84
CD4+ T Cells, donor3	11382-118B5	204.04	20.13	9.15	1.52	1.22	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	119.45	9.95	6.38	0.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	147.79	14.37	9.88	0.45	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	171.04	14.66	9.49	1.15	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	171.15	18.96	9.01	0.95	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	201.57	17.56	5.62	2.81	1.40	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	210.96	19.78	6.59	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	105.64	9.25	4.77	0.58	0.43	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	115.40	9.32	4.91	0.68	1.02	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	98.98	7.42	4.67	0.81	1.29	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	151.97	15.69	10.31	1.79	0.45	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	154.78	17.12	7.69	1.40	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	171.59	13.64	9.24	0.88	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	121.85	10.54	10.96	0.42	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	110.95	12.47	5.61	1.45	0.62	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	101.57	8.02	5.68	0.33	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	220.81	22.03	14.14	1.36	1.36	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	261.01	23.58	13.93	1.61	0.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	220.57	30.48	5.38	3.59	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	100.69	11.13	6.12	1.11	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	92.93	10.40	3.25	0.00	0.65	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	112.64	11.98	6.72	0.42	0.21	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	122.86	13.15	9.10	0.00	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	134.31	12.13	9.10	1.30	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	113.31	18.74	12.64	0.87	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	149.45	13.86	8.91	1.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	128.32	6.46	4.62	1.85	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	117.25	13.96	5.58	1.40	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	121.29	12.46	8.03	0.55	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	130.30	14.48	8.10	0.49	0.98	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	147.84	16.94	3.08	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	123.19	9.67	8.59	1.07	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	98.33	8.31	4.15	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	215.10	18.66	4.91	0.65	1.64	0.33
CD8+ T Cells, donor2	11307-117C2	176.45	10.51	2.63	2.25	1.50	0.00
CD8+ T Cells, donor3	11383-118B6	246.43	18.94	5.05	4.04	2.52	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	36.01	5.28	1.38	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.03	5.27	0.48	0.72	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	30.92	3.56	0.55	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.61	1.50	0.30	0.60	0.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	35.28	6.96	2.40	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	38.43	5.23	1.14	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	38.02	5.00	0.87	1.74	0.43	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	41.59	7.37	0.26	0.00	0.26	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	39.16	4.92	0.94	0.70	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.92	7.85	0.60	0.60	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	35.44	6.39	0.58	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	42.36	5.33	0.80	0.27	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	68.73	11.38	0.88	0.88	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	68.77	9.11	1.37	1.37	0.00	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	73.84	5.22	0.75	2.24	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	34.21	7.20	0.72	0.72	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	40.57	6.04	0.86	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	32.05	3.30	0.71	0.00	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	31.37	3.49	1.58	0.32	0.95	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	40.60	7.07	1.23	0.62	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	40.71	5.45	1.28	0.96	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	41.31	4.59	1.15	0.38	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	32.71	4.73	1.58	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	35.55	5.29	0.76	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	74.67	12.85	0.80	3.21	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	73.44	13.29	0.00	0.70	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	60.11	10.02	0.00	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	73.11	1.83	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	30.14	3.95	0.00	0.00	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	33.15	2.95	0.84	0.74	0.53	0.32
Chondrocyte - de diff, donor1	11261-116G1	36.40	1.39	0.69	1.39	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	42.29	0.36	0.71	0.71	1.07	0.71
Chondrocyte - de diff, donor3	11410-118E6	23.67	1.02	0.11	0.23	0.23	0.57
Chondrocyte - re diff, donor2	11339-117F7	28.65	1.79	0.00	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	36.80	3.24	0.81	0.40	0.40	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	34.54	3.44	1.61	0.57	0.00	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	42.75	3.21	1.92	0.43	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	45.40	3.36	1.06	0.62	0.18	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	70.88	3.21	1.01	1.93	2.11	1.65
Corneal Epithelial Cells, donor1	11526-119I5	38.43	2.85	1.98	0.22	0.22	0.44
Corneal Epithelial Cells, donor2	11606-120I4	26.16	0.00	2.28	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	34.51	1.53	1.53	0.26	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	86.34	5.94	2.15	0.50	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	78.54	10.72	0.63	1.58	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	41.79	5.29	0.54	0.65	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	32.46	1.71	0.34	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	16.97	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	22.75	0.48	0.48	1.45	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	21.68	2.67	1.83	0.50	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	26.99	4.69	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	34.50	4.81	1.41	0.57	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	44.43	2.75	2.36	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	29.96	3.78	1.16	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	28.47	3.76	0.94	0.24	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	30.50	3.68	1.75	0.53	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	31.03	3.99	2.44	0.44	0.66	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	41.38	3.96	1.52	0.30	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	31.86	4.79	3.38	0.28	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	30.31	0.89	1.78	1.19	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	39.05	2.08	1.56	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	28.07	4.25	0.85	0.28	0.71	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	16.81	1.60	2.00	2.00	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	37.21	2.62	2.62	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	34.79	4.22	2.24	0.50	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	26.72	2.82	2.17	0.22	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	26.14	2.81	2.20	0.12	0.12	0.61
Endothelial Cells - Vein, donor1	11267-116G7	31.85	4.55	2.28	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	39.81	5.59	3.49	0.00	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	28.89	5.50	2.51	0.31	0.31	1.10
Eosinophils, donor1	12244-129H3	76.23	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	254.14	21.45	33.01	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	192.61	24.97	35.67	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	34.69	2.93	0.49	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	4.16	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	69.38	2.05	0.00	0.82	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	21.35	0.77	0.11	0.66	0.55	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	34.88	2.06	0.54	0.76	0.54	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	36.87	2.67	0.85	0.73	0.36	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	31.52	0.55	0.41	1.09	0.55	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	42.82	1.37	0.32	1.05	0.95	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.45	1.32	0.79	0.00	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	32.22	1.33	0.66	0.33	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	43.09	2.27	0.45	0.45	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	116.72	6.82	3.79	2.27	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	38.33	3.94	0.95	0.63	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	56.68	2.42	0.30	1.82	0.91	0.30
Fibroblast - Cardiac, donor5	11456-119A7	55.71	5.58	1.14	1.02	0.51	0.38
Fibroblast - Cardiac, donor6	11460-119B2	55.33	5.61	1.21	1.06	0.45	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	65.25	3.22	1.07	0.94	0.54	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	60.83	0.86	0.86	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	46.87	5.86	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	45.67	1.85	1.15	1.15	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	40.20	0.85	0.34	1.19	0.34	1.02
Fibroblast - Dermal, donor1	11269-116G9	19.72	0.70	0.23	0.00	0.94	0.47
Fibroblast - Dermal, donor2	11346-117G5	37.26	3.77	1.42	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.61	2.30	0.36	0.48	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	30.41	3.17	1.02	0.23	0.57	0.23
Fibroblast - Dermal, donor5	11454-119A5	41.69	1.57	1.05	0.87	0.35	0.52
Fibroblast - Dermal, donor6	11458-119A9	44.02	1.95	1.30	0.97	0.32	0.49
Fibroblast - Gingival, donor1	11237-116D4	32.07	0.00	0.42	0.62	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	60.78	3.67	1.57	1.05	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	24.51	1.32	0.26	0.53	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	38.87	1.16	0.39	0.39	0.29	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	30.13	4.16	1.04	0.00	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.77	1.59	0.70	0.18	1.06	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	45.99	1.25	1.09	1.56	0.47	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	31.24	1.89	0.27	0.81	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	92.81	4.23	0.71	4.23	2.47	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	47.97	2.78	0.88	0.58	0.29	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	38.32	1.91	0.55	1.09	0.14	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	42.56	2.30	0.66	0.22	0.44	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	46.81	1.47	1.03	2.05	0.59	0.73
Fibroblast - Lung, donor1	11270-116H1	27.19	5.44	2.72	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	26.86	4.48	0.00	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	23.21	1.69	0.42	0.00	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	74.97	5.00	3.33	0.83	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	40.56	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	45.06	0.28	1.12	1.12	0.56	0.28
Fibroblast - Mammary, donor1	11540-120B1	69.83	6.50	2.44	0.81	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	55.92	3.99	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.40	1.94	0.19	0.19	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	37.47	3.49	1.06	0.30	0.61	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	42.53	2.45	0.31	0.61	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	43.89	3.43	0.76	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	33.48	2.16	0.27	0.27	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	43.03	1.86	0.58	1.04	0.23	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	40.23	2.21	0.88	0.77	0.33	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	47.95	1.63	1.02	1.02	0.61	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	41.43	2.00	0.67	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	1.19	0.40	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	34.53	3.18	1.19	0.40	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	38.54	1.95	0.18	0.18	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	43.16	4.73	0.59	0.20	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	34.60	0.90	0.60	0.30	0.90	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	33.68	3.56	1.19	0.86	0.54	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	34.42	1.52	0.25	0.76	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	48.73	3.12	0.33	0.16	0.82	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	54.14	1.20	0.20	1.40	2.01	0.40
Fibroblast - skin normal, donor2	11561-120D4	48.12	2.71	0.80	0.30	0.70	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	44.43	1.51	1.21	0.91	1.51	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	46.73	2.49	0.75	1.08	0.50	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	41.54	2.39	0.34	0.51	0.68	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	31.20	1.64	1.31	1.31	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	32.92	2.88	0.43	0.53	0.32	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	44.36	1.52	0.51	0.51	0.34	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.66	2.98	0.78	0.16	0.16	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	72.34	2.61	0.87	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	28.43	1.04	0.52	0.35	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	33.83	2.34	0.78	0.78	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	35.01	1.02	0.51	0.26	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	19.90	0.77	2.30	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	19.14	3.83	3.83	0.00	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	13.41	2.28	3.42	0.29	0.29	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.57	6.34	3.86	1.10	0.83	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	53.20	2.51	3.88	0.91	1.60	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	30.31	2.97	2.97	0.59	0.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	35.69	3.70	3.97	1.06	0.79	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	56.10	2.61	0.98	0.98	1.30	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	16.36	1.77	1.77	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	17.67	1.55	2.26	0.28	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	22.54	2.59	1.35	0.49	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	10.48	1.61	1.88	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	27.13	4.34	3.22	0.37	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	21.32	5.12	3.74	0.00	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.89	4.68	2.03	0.00	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	32.86	3.88	3.42	0.23	0.23	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	28.15	3.61	2.37	0.62	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	34.10	5.03	5.03	0.66	0.22	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	32.80	2.07	1.18	0.89	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	30.68	4.45	1.75	0.79	0.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.03	4.92	2.23	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	23.39	3.02	0.81	0.00	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	27.48	2.21	1.53	0.17	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	42.74	3.46	1.33	0.09	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	49.11	4.37	3.43	0.83	0.52	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	46.11	4.61	2.05	0.17	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	29.77	2.21	1.44	0.44	0.11	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.52	1.91	1.50	0.75	0.33	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.14	3.06	1.02	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	27.64	1.86	1.03	0.21	0.21	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	28.36	3.23	1.38	0.23	0.23	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	23.51	3.00	1.67	0.50	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	25.13	1.76	0.44	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.20	2.21	1.35	0.49	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.83	2.11	0.81	0.32	0.16	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	36.56	3.21	2.57	0.64	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	25.30	2.46	1.61	0.76	0.19	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	25.15	2.53	2.21	0.16	0.47	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.06	3.34	1.52	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.18	2.93	1.67	0.21	0.42	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	31.18	4.39	1.10	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	28.05	1.40	1.68	0.00	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.96	1.67	0.74	0.46	0.46	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	16.58	0.80	0.27	1.07	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	23.56	2.30	0.61	0.00	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.21	2.20	0.39	0.00	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.92	1.63	0.54	0.27	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.65	2.58	0.74	0.55	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.98	1.97	0.44	0.88	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	49.59	1.98	0.99	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	27.97	1.85	0.79	0.40	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	30.06	2.22	1.21	0.40	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	59.47	2.54	1.02	0.25	0.51	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	14.53	1.99	2.39	0.20	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	10.63	1.69	2.93	0.00	0.31	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	16.98	1.64	3.27	0.41	0.20	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	22.84	3.13	2.82	0.63	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	16.95	0.57	1.41	0.28	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	11.53	2.31	1.84	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	7.42	7.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	16.63	1.55	1.93	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	25.67	0.00	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	3.48	3.48	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	13.02	1.95	2.28	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	16.47	2.06	1.65	0.00	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	6.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	22.37	2.52	0.84	0.56	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	23.53	2.29	0.65	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	26.84	0.84	1.68	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.22	2.86	1.27	0.64	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	16.64	5.09	1.70	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	4.18	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	25.77	2.29	1.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.83	2.07	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	23.20	1.24	1.24	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	20.25	2.07	1.61	0.69	0.23	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.52	1.92	1.92	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	30.97	2.28	0.33	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	46.15	4.01	1.34	0.00	0.67	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	33.90	5.78	2.31	0.00	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	42.79	5.48	1.03	0.34	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	72.06	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	41.99	3.30	1.89	0.47	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	46.47	3.02	1.21	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	43.75	5.09	1.53	0.51	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	35.10	2.79	1.20	0.00	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	44.90	3.95	1.97	1.97	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	7.08	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	46.68	4.08	0.58	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	38.62	4.39	1.76	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	3.39	2.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	39.99	2.98	1.19	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	29.11	0.49	0.97	0.49	0.97	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	37.66	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	31.60	0.83	0.42	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	53.97	1.12	0.00	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.32	1.59	0.63	0.63	0.95	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	18.38	0.84	0.42	0.84	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	21.93	0.93	0.12	0.12	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	22.96	0.17	0.17	0.17	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	22.30	1.59	0.46	0.00	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.64	1.64	0.44	0.11	0.33	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	17.84	0.64	0.21	0.21	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	24.11	1.08	0.65	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	17.93	0.87	0.62	0.12	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	18.87	0.51	0.34	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	21.46	0.96	0.00	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.18	6.72	4.48	0.56	2.80	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	51.07	6.49	3.03	1.30	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	5.29	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	82.54	3.53	1.41	2.82	1.06	2.47
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	114.79	5.81	0.73	1.45	2.91	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.02	3.15	0.52	1.05	0.00	0.17
Hepatocyte, donor1	11523-119I2	9.68	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	19.39	2.15	3.23	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	12.88	1.23	0.61	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	11.10	0.65	1.31	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	24.29	1.75	0.87	0.17	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	27.17	2.33	0.41	0.27	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	3.18	0.00	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	48.73	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	41.03	2.65	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	26.61	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	19.53	0.00	0.00	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	29.72	1.29	0.65	0.65	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	22.54	3.22	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	32.60	0.00	1.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	27.71	0.84	0.42	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	27.33	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.05	0.00	0.47	0.47	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	20.86	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	31.21	1.08	1.08	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	27.95	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	28.06	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.28	1.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	20.99	0.31	0.00	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	0.00	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	35.46	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	55.33	0.00	4.43	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	38.36	0.00	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	37.34	1.07	1.07	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	34.06	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	51.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	6.21	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	38.07	0.00	0.00	1.06	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	34.68	1.14	0.73	0.33	0.00	0.08
Keratinocyte - epidermal, donor2	11349-117G8	32.21	1.76	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	18.74	0.95	0.19	0.28	0.09	0.09
Keratinocyte - oral, donor1	11251-116E9	31.78	3.41	1.36	0.45	0.11	0.57
Keratocytes, donor1	11527-119I6	33.01	2.06	1.03	0.69	0.00	0.34
Keratocytes, donor2	11607-120I5	36.33	4.69	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	16.60	0.99	0.40	0.59	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	46.16	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	24.81	1.08	2.16	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	26.64	2.88	0.69	1.04	0.92	0.23
Lens Epithelial Cells, donor3	11690-122I7	88.90	3.33	1.21	1.72	0.71	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	29.53	2.02	1.54	0.24	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	17.58	1.67	1.40	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	20.62	2.20	1.10	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	13.98	1.08	2.15	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.70	1.89	1.89	0.63	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	15.96	1.40	0.32	0.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.36	1.64	0.41	0.41	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.43	1.01	0.76	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	17.03	2.53	1.55	0.42	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.05	1.19	1.58	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.15	0.97	1.36	0.39	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.22	0.74	1.11	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.38	1.74	1.39	0.35	0.00	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	17.89	1.19	0.95	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.54	2.06	0.82	0.41	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.71	0.92	1.85	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.78	1.25	0.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.21	1.28	1.10	0.55	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	16.46	1.32	0.33	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.82	2.34	1.46	0.00	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.17	1.74	1.49	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.40	1.94	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	16.70	1.62	0.27	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	18.62	1.97	0.91	0.15	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.41	1.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.91	1.26	1.47	0.63	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	15.64	2.11	1.65	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	16.51	1.38	0.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	14.68	1.51	1.32	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.13	2.97	0.74	0.21	0.32	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	19.38	0.97	1.45	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	1.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	17.59	2.60	0.99	0.25	0.12	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	20.36	2.96	1.11	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.33	0.74	0.49	0.00	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	17.87	2.34	1.10	0.14	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	19.30	1.61	1.29	0.32	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.09	1.22	0.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	15.82	1.82	0.56	0.28	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	15.64	2.13	0.36	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.45	0.97	0.48	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	20.07	1.87	2.02	0.31	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	21.13	2.51	1.43	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	21.89	0.98	0.65	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	20.95	1.88	0.47	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	29.70	2.10	2.48	0.74	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.83	2.05	1.79	0.00	0.26	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	12.53	2.09	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	140.49	9.06	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	140.39	8.44	3.84	1.53	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	103.91	6.68	0.74	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	177.29	9.31	1.69	1.27	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	126.60	5.63	0.70	0.00	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	105.54	7.47	0.93	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	109.75	4.64	2.06	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	83.26	4.76	2.38	0.00	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	140.24	6.33	1.36	0.68	0.68	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	94.23	5.53	2.04	1.16	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	85.98	7.65	1.35	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	188.73	9.35	2.17	0.68	0.54	1.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	145.33	10.78	3.08	1.03	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	99.51	6.00	1.76	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	73.29	4.00	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	138.55	6.62	2.55	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	106.46	5.87	1.87	0.53	1.07	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	102.97	7.37	1.13	1.13	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	150.32	8.59	3.68	1.23	1.84	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	144.33	9.79	3.26	1.63	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	98.71	6.04	1.67	0.62	0.62	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	114.63	4.20	1.12	0.00	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	155.58	15.46	2.06	1.03	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	115.83	8.71	1.16	0.29	0.58	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	94.46	3.29	0.90	0.00	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	91.84	7.75	0.55	0.00	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	164.02	9.90	1.77	0.71	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	128.34	5.90	3.32	0.74	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	118.58	8.06	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	150.05	8.83	1.54	0.38	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	143.80	7.93	2.26	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	117.33	5.74	1.64	0.00	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	158.61	9.49	1.36	0.00	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	141.47	10.05	5.03	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	115.02	8.22	1.49	0.00	2.99	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	162.01	11.15	4.46	0.37	1.86	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	107.69	5.60	0.86	0.43	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	107.89	8.56	0.86	1.71	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	139.60	6.33	2.33	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	155.05	8.45	2.41	0.60	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	115.18	13.51	3.55	0.00	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	123.39	8.25	2.75	0.34	1.72	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	140.09	11.27	1.07	0.54	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	120.53	9.43	1.35	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	137.42	8.15	1.85	1.11	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	129.09	3.49	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	116.35	9.52	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	136.05	7.60	3.60	0.80	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	191.17	5.09	2.91	0.73	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	179.36	10.73	0.77	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	168.21	6.91	1.97	0.99	1.48	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	142.08	2.82	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	167.44	12.07	3.02	0.00	0.00	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	155.47	9.46	3.60	0.90	0.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	165.23	13.77	5.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	151.42	12.47	3.12	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	163.45	8.60	3.52	0.39	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	122.05	4.62	1.98	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	137.00	8.82	2.59	2.59	1.56	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	173.28	10.06	1.31	1.75	0.88	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	135.86	7.83	0.00	0.56	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	133.38	10.16	3.09	0.88	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	123.43	5.40	3.86	0.39	0.77	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	122.54	4.56	3.04	1.01	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	120.64	8.65	0.96	0.48	0.00	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	143.12	8.35	2.78	0.80	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	128.82	4.25	1.82	1.22	1.22	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	88.54	8.99	1.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	124.26	8.74	1.90	1.52	0.76	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	137.88	6.71	3.10	1.03	1.55	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	96.74	7.86	1.81	0.00	0.60	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	125.81	9.51	0.63	0.63	0.32	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	149.26	8.00	2.67	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	114.93	6.32	1.72	1.15	1.15	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	159.93	9.26	1.54	1.03	2.06	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	173.30	9.20	2.83	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	123.14	7.94	3.40	0.57	1.13	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	139.37	8.74	2.08	0.83	1.25	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	159.74	3.92	1.57	0.00	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	98.54	6.68	1.67	0.84	0.84	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	169.59	10.69	2.79	0.93	2.79	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	117.75	7.36	2.01	2.01	2.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	124.57	9.62	0.00	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	137.80	9.70	2.42	1.21	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	147.76	11.01	4.59	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	130.70	12.45	1.78	0.00	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	160.13	15.96	1.71	1.14	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	161.05	9.97	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	106.70	6.02	2.74	1.09	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	138.53	11.58	1.78	1.34	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	184.05	9.62	3.64	1.04	0.26	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	110.08	12.60	3.98	0.66	2.65	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	189.15	8.31	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	39.66	1.60	0.68	0.23	0.68	0.68
Macrophage - monocyte derived, donor2	11313-117C8	26.79	4.22	0.18	0.18	0.73	0.18
Macrophage - monocyte derived, donor3	11389-118C3	31.85	3.01	0.92	0.13	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.40	0.53	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	21.39	0.79	0.32	0.16	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	18.76	0.28	0.28	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	18.14	0.40	0.80	0.50	0.10	0.20
Mammary Epithelial Cell, donor2	11350-117G9	16.21	0.58	1.16	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	30.43	1.75	1.25	0.00	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	11.52	2.03	0.00	1.36	0.00	2.03
Mast cell, donor1	11563-120D6	74.18	6.16	2.70	1.08	1.19	0.54
Mast cell, donor2	11565-120D8	115.90	11.29	5.35	1.49	2.08	1.19
Mast cell, donor3	11566-120D9	142.28	9.46	8.10	1.80	4.05	1.35
Mast cell, donor4	11567-120E1	143.78	19.86	8.69	1.60	3.19	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	54.34	8.54	3.44	1.00	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	98.64	1.75	0.00	2.92	1.17	1.75
Mast cell, expanded, donor5	11939-126A4	56.33	4.13	2.29	0.46	0.23	0.34
Mast cell, expanded, donor8	11941-126A6	211.72	5.86	2.85	4.69	2.68	2.01
Melanocyte - dark, donor1	11502-119F8	19.10	2.98	1.49	0.10	0.10	0.20
Melanocyte - dark, donor2	11582-120F7	25.61	4.15	0.69	1.38	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	22.89	4.35	0.80	0.58	0.22	0.07
Melanocyte - light, donor1	11274-116H5	45.84	4.70	2.12	0.71	1.18	0.47
Melanocyte - light, donor2	11351-117H1	50.50	6.82	1.36	0.68	0.68	0.68
Melanocyte - light, donor3	11423-118G1	27.75	2.60	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	17.39	2.60	1.04	0.21	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	19.36	1.08	0.27	0.81	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	16.61	1.07	0.27	0.54	0.00	0.00
Meningeal Cells, donor1	11493-119E8	56.57	3.85	2.48	0.25	0.62	1.12
Meningeal Cells, donor2	11573-120E7	44.90	1.76	1.32	0.44	0.88	0.88
Meningeal Cells, donor3	11654-122E7	29.18	1.47	1.22	0.24	0.16	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.10	1.71	0.86	0.00	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	95.00	3.22	0.50	1.51	0.70	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	84.11	5.26	2.63	5.26	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	34.01	2.62	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.79	2.15	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	39.18	4.02	0.64	0.64	1.06	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	34.18	2.01	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	42.19	3.96	2.64	0.44	1.10	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	32.15	3.65	2.19	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	39.90	3.89	1.64	0.82	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.99	0.69	0.42	0.69	0.42	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	89.59	1.12	0.00	1.12	0.74	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	43.81	1.45	0.66	0.26	0.39	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	27.89	0.89	0.30	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	46.71	2.34	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	73.65	4.48	0.64	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	19.49	1.06	0.71	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	32.21	1.56	0.00	0.31	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	40.64	5.81	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	45.88	1.33	0.00	0.80	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	45.04	0.00	0.00	1.50	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	52.90	1.16	0.43	0.72	0.36	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	44.56	5.40	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	23.64	5.42	0.74	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	23.56	6.48	1.47	0.59	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	48.40	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.01	2.17	0.93	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	16.39	2.07	0.21	0.83	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	4.63	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	20.77	4.75	1.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.14	4.19	0.47	0.93	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.31	4.06	0.81	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	24.95	3.96	0.79	1.19	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	14.16	3.54	1.77	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	17.48	2.28	0.76	0.76	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	35.53	3.95	1.32	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.64	2.97	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	3.68	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	15.80	1.49	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	23.47	5.03	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.29	1.51	0.25	0.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.97	2.85	0.48	0.48	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.95	1.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.81	2.30	0.69	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.72	4.42	1.05	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.19	2.04	1.02	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.16	0.86	0.43	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.45	2.22	0.44	0.22	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.20	1.10	0.88	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.31	1.52	0.00	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	13.32	2.17	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.82	2.06	1.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	4.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	0.96	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	17.61	1.20	0.80	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	1.37	1.37	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.51	1.50	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	6.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.20	2.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	25.38	0.00	0.00	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.73	2.56	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.42	0.50	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	19.49	4.87	0.70	1.39	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	30.94	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.65	2.05	0.00	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	20.13	1.75	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.53	2.13	0.00	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.78	1.12	0.28	0.84	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.47	2.49	0.42	0.00	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	23.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.78	1.51	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	21.29	2.50	0.00	1.25	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	18.47	0.92	0.00	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	17.64	2.28	1.14	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	16.03	1.80	0.00	0.14	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.63	1.30	0.78	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	24.02	3.43	0.43	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.06	2.54	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.55	1.07	0.80	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	33.23	2.39	0.60	0.00	1.20	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.66	1.41	0.28	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.74	1.27	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.89	1.55	1.11	0.00	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	21.99	0.38	0.00	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	17.90	0.85	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.14	2.21	1.47	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	25.42	1.96	1.30	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.64	1.18	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.10	1.73	0.29	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	32.15	3.30	0.00	0.41	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.69	2.08	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.33	1.97	0.00	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	27.48	1.38	0.79	0.40	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	30.73	1.86	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.78	1.50	1.13	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	15.18	2.93	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.36	0.45	0.57	0.11	0.11	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	23.45	0.73	0.37	0.73	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	4.67	1.56	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	1.60	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	11.81	2.11	0.84	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	1.51	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	12.55	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.45	1.94	0.65	0.86	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.67	2.09	1.05	0.00	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	42.72	1.33	1.33	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	62.19	2.09	0.00	0.42	1.67	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	25.86	0.57	0.00	1.33	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	82.98	4.79	0.00	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.92	0.68	0.00	0.00	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	38.09	1.26	0.42	2.51	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	46.49	2.09	0.00	0.93	0.70	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	47.56	0.81	0.27	1.62	1.08	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	38.47	1.68	1.26	1.68	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	41.69	0.00	0.00	1.49	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	21.65	0.27	0.00	0.81	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	35.82	1.81	0.45	1.81	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	44.09	0.49	0.16	2.29	1.14	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	36.09	1.82	0.00	1.82	0.36	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	53.04	1.06	0.00	2.12	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	47.42	0.60	0.00	2.40	0.60	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.83	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	40.33	0.81	0.00	1.95	0.65	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.92	0.88	0.35	1.76	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	47.12	0.70	0.00	1.41	1.41	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	52.87	0.92	0.00	5.98	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	51.42	2.25	0.00	1.93	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	13.80	0.00	0.00	0.69	0.69	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	0.00	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	34.53	1.78	0.45	1.11	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	45.30	0.42	0.42	0.85	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	33.23	1.42	0.00	1.42	0.24	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	46.79	1.29	0.43	3.00	0.43	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	48.65	2.33	0.33	1.67	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	42.83	3.16	0.90	0.90	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	33.73	1.19	0.40	0.40	0.79	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	52.93	0.93	0.93	4.64	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.00	2.65	0.38	1.51	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	45.30	2.93	0.33	0.98	1.63	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	58.83	1.31	0.00	1.31	0.87	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	46.59	3.17	1.81	0.90	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	49.39	4.41	0.00	3.53	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	47.87	1.33	0.66	0.66	0.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	35.22	2.48	0.00	0.99	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	40.20	1.53	0.77	1.91	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.99	1.21	0.30	0.60	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	41.11	3.76	0.66	0.66	0.22	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	33.88	4.07	0.00	2.03	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	55.48	3.66	0.00	4.27	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	54.45	1.26	0.00	1.57	0.00	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	42.07	1.82	0.00	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	51.42	7.12	1.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	13.60	1.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	27.45	0.50	0.00	1.24	0.62	0.25
Myoblast, donor2	11322-117D8	37.59	3.07	0.38	1.15	0.58	0.38
Myoblast, donor3	11398-118D3	42.88	1.68	0.67	1.01	1.18	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	47.72	3.50	2.04	0.58	0.58	0.00
Natural Killer Cells, donor1	11230-116C6	163.29	15.99	4.61	2.15	0.62	0.31
Natural Killer Cells, donor2	11311-117C6	154.40	10.86	3.62	2.41	2.41	0.90
Natural Killer Cells, donor3	11387-118C1	166.02	14.91	3.31	2.02	2.39	0.55
Neural stem cells, donor1	11275-116H6	64.60	3.99	3.27	0.36	1.45	0.36
Neural stem cells, donor2	11352-117H2	103.98	5.78	5.78	1.93	1.93	0.00
Neurons, donor1	11494-119E9	23.90	3.41	0.00	1.14	0.00	1.14
Neurons, donor2	11574-120E8	36.99	1.10	0.22	0.22	0.00	0.44
Neurons, donor3	11655-122E8	29.60	2.47	0.00	2.47	0.00	0.00
Neutrophils, donor1	11233-116C9	202.31	20.42	12.06	1.86	0.00	0.00
Neutrophils, donor2	11314-117C9	373.96	26.09	5.80	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	501.50	17.71	21.99	1.22	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	37.88	2.26	0.71	0.47	0.47	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	27.68	0.65	0.33	0.00	0.98	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	21.66	1.60	0.40	0.20	0.40	0.60
Olfactory epithelial cells, donor1	11933-125I7	56.02	1.93	0.69	1.38	0.55	0.41
Olfactory epithelial cells, donor2	11934-125I8	48.49	2.75	0.29	0.87	0.29	0.43
Olfactory epithelial cells, donor3	11935-125I9	46.08	1.25	0.57	0.91	0.34	0.45
Olfactory epithelial cells, donor4	11936-126A1	80.06	1.85	0.49	1.66	0.68	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	30.09	3.01	3.61	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	69.55	3.83	0.85	0.64	0.43	1.49
Osteoblast - differentiated, donor2	11353-117H3	51.44	2.29	0.00	1.14	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	26.07	0.62	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	62.15	3.52	1.37	0.59	0.59	0.98
Osteoblast, donor2	11354-117H4	41.44	2.81	2.81	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	54.92	3.38	1.42	1.42	0.53	0.53
Pancreatic stromal cells, donor1	11249-116E7	29.06	1.18	0.51	0.51	0.42	0.25
Pericytes, donor1	11491-119E6	64.87	3.23	2.78	1.45	0.78	1.45
Pericytes, donor2	11571-120E5	54.78	2.04	1.58	0.68	0.91	0.91
Pericytes, donor3	11652-122E5	68.97	3.46	0.61	1.63	0.41	0.41
Perineurial Cells, donor1	11499-119F5	25.09	1.36	0.68	0.45	0.57	0.11
Perineurial Cells, donor2	11579-120F4	43.43	3.86	1.47	0.92	0.37	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	155.86	8.92	10.84	1.59	1.59	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	111.66	9.55	5.39	0.73	0.98	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	125.66	9.97	4.53	1.16	1.04	0.26
Placental Epithelial Cells, donor1	11278-116H9	23.20	0.24	0.24	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	31.05	1.11	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	23.36	0.98	0.98	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	48.73	4.43	0.63	1.58	0.32	0.95
Preadipocyte - breast, donor1	11467-119B9	65.66	4.13	0.38	0.75	0.19	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	47.77	0.52	1.17	1.44	0.91	1.04
Preadipocyte - breast, donor2	11328-117E5	51.78	2.48	2.03	1.13	0.68	0.68
Preadipocyte - omental, donor1	11468-119C1	55.52	2.13	0.64	0.43	0.53	0.85
Preadipocyte - omental, donor2	11329-117E6	82.06	3.06	0.00	0.87	2.18	0.44
Preadipocyte - omental, donor3	11403-118D8	79.07	5.16	0.43	0.72	1.00	0.86
Preadipocyte - perirenal, donor1	11469-119C2	46.26	0.98	0.00	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	105.65	6.45	1.84	4.30	0.31	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	32.76	2.66	1.06	0.53	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	33.38	1.70	0.17	1.02	0.68	0.68
Preadipocyte - visceral, donor1	11280-116I2	38.00	1.77	0.84	0.65	0.37	0.56
Preadipocyte - visceral, donor2	11357-117H7	28.07	0.92	0.46	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	25.39	1.67	0.42	0.63	0.52	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	21.72	1.51	1.21	0.30	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	37.10	2.03	0.41	1.22	0.68	0.41
Prostate Epithelial Cells, donor3	11404-118D9	10.04	0.49	0.43	0.06	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	26.77	1.59	0.46	0.23	0.57	0.23
Prostate Stromal Cells, donor2	11332-117E9	21.70	1.61	0.36	0.00	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	25.96	1.15	0.42	0.94	0.52	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	46.35	4.01	2.55	1.46	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	25.09	1.87	1.18	0.49	0.07	0.28
Renal Epithelial Cells, donor1	11517-119H5	60.36	6.09	4.57	2.54	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	46.24	4.27	1.42	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	32.92	2.54	2.01	0.42	0.00	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	34.04	3.40	2.72	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	30.86	2.43	0.67	0.67	0.54	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	35.97	2.89	1.33	0.44	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	34.60	4.66	1.33	0.00	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	68.67	3.52	1.76	0.66	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	77.75	0.63	0.63	1.88	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	55.20	4.16	1.94	0.55	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	41.87	2.95	3.49	0.81	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	28.25	2.11	2.11	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	49.37	4.05	1.93	0.39	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.96	2.33	0.52	0.00	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	78.74	8.81	3.13	1.71	1.42	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	42.19	5.15	3.09	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.08	1.00	0.50	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	32.47	2.54	1.87	0.40	0.53	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	22.34	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	9.36	0.00	0.55	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	17.98	0.00	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	18.72	0.52	0.26	0.39	0.26	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	19.96	0.50	0.40	0.10	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	26.55	0.56	0.67	0.00	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	15.01	1.24	0.37	0.37	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.86	0.47	0.12	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	23.58	0.69	0.69	0.69	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	16.98	0.27	0.14	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	19.51	0.91	0.45	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	25.45	0.72	1.25	0.54	0.54	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	16.35	1.15	0.14	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.35	0.64	0.11	0.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	19.47	1.99	1.11	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.35	0.76	0.38	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	18.91	1.02	0.37	0.00	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.05	0.75	1.13	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	20.17	0.53	0.27	0.40	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.64	0.39	0.39	0.10	0.10	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	16.23	0.38	0.19	0.19	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	19.22	0.53	0.32	0.21	0.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.86	1.68	0.28	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	19.14	0.51	0.68	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	21.33	0.91	0.00	0.00	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	20.23	0.86	0.61	0.37	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	22.30	1.21	0.54	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	18.40	0.71	0.47	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	18.25	0.00	0.60	0.79	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.30	0.94	0.23	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	19.28	0.62	0.00	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	20.57	0.66	0.44	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	18.80	1.46	0.63	0.63	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	20.46	0.94	0.54	0.27	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.61	0.68	0.17	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	18.70	0.96	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	21.49	0.52	0.52	0.34	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.04	0.82	0.14	0.69	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	21.34	0.49	0.33	0.66	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.77	1.02	0.34	0.17	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	23.67	0.30	0.44	0.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	22.92	0.27	0.00	0.00	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	15.62	0.97	0.28	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	18.57	0.95	0.00	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.87	1.01	0.81	0.20	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	17.05	0.75	0.28	0.09	0.09	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	22.71	1.05	1.40	1.40	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	18.74	0.60	0.30	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	17.62	0.73	0.24	0.37	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	57.35	2.47	1.60	1.02	0.29	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	25.55	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.67	0.90	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	20.36	1.13	0.90	0.45	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	27.26	2.10	0.30	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	18.42	1.06	1.06	0.59	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.33	1.28	0.43	0.43	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	35.46	1.20	1.80	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	54.16	2.44	2.26	0.56	0.75	0.38
Schwann Cells, donor2	11578-120F3	23.82	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	28.70	1.97	0.88	0.88	0.00	0.66
Sebocyte, donor1	11220-116B5	75.59	4.93	0.55	1.64	0.55	1.10
Sebocyte, donor2	11301-117B5	31.71	1.38	0.00	0.00	0.00	0.92
Sebocyte, donor3	11378-118B1	24.53	1.65	0.41	0.82	0.21	0.41
Sertoli Cells, donor1	11255-116F4	49.70	1.66	0.00	1.66	0.00	4.97
Sertoli Cells, donor2	11333-117F1	62.14	0.00	0.00	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	32.99	2.73	1.23	0.44	0.00	0.26
Skeletal Muscle Cells, donor2	11358-117H8	40.48	2.89	0.72	0.00	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	67.72	3.34	2.51	0.00	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	20.27	1.89	0.63	0.16	0.63	0.16
Skeletal Muscle Cells, donor5	11455-119A6	20.66	2.08	0.89	0.45	0.30	0.59
Skeletal Muscle Cells, donor6	11459-119B1	25.55	2.92	1.08	0.46	0.46	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	29.86	2.27	1.01	0.63	0.13	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	32.96	5.28	1.85	0.43	0.43	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.94	2.98	1.49	0.10	0.20	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	31.85	2.19	0.59	0.59	0.34	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	53.56	5.07	1.45	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	34.95	1.65	0.55	0.55	0.55	0.28
Skin - palm, donor1	10286-104F7	96.70	0.00	0.00	2.69	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	23.07	1.59	0.58	0.72	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	161.12	9.00	3.27	3.27	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.43	1.69	0.39	1.04	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	20.85	1.67	0.97	0.56	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	37.84	2.53	1.13	0.84	0.42	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	97.69	5.71	3.17	1.90	1.48	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	19.86	1.20	0.22	0.00	0.15	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	53.08	2.16	0.00	0.31	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	24.68	0.44	0.22	0.67	0.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	56.43	0.59	1.18	2.94	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	36.24	2.87	0.44	0.44	1.33	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	55.92	2.36	0.79	1.18	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	71.08	1.55	0.00	1.55	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	17.01	1.00	0.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	68.40	4.13	1.73	1.20	0.93	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	19.06	1.33	0.22	0.89	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.42	0.38	0.13	0.51	0.13	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	24.42	0.33	0.98	0.65	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	40.75	1.77	0.30	0.00	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	48.69	1.85	0.28	1.57	1.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	43.92	2.60	1.14	0.49	0.49	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	23.75	1.22	0.00	1.22	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	89.91	7.07	1.77	1.26	1.26	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	73.45	0.00	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	71.05	3.34	1.43	1.43	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	25.81	1.18	0.15	0.44	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	34.01	1.51	0.86	0.22	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	25.92	1.15	0.42	0.42	0.31	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	68.21	3.71	0.93	1.86	0.62	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	95.93	3.23	3.23	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	43.63	2.09	0.90	0.90	1.79	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	54.28	2.05	1.02	0.68	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	25.99	1.49	0.16	0.39	0.24	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	48.81	2.01	0.70	2.72	1.11	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	34.59	2.50	0.46	0.46	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	97.82	3.02	0.00	1.21	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	18.81	1.85	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.30	1.07	0.40	0.40	0.40	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	27.42	0.88	0.25	0.88	0.25	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	30.69	0.51	0.25	0.76	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	66.79	1.36	0.75	1.21	0.30	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	51.01	6.00	1.50	2.25	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	65.90	2.58	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	130.22	6.51	0.00	4.19	1.86	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	38.37	1.01	0.00	0.50	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	52.65	3.76	0.94	1.88	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	33.63	1.18	1.47	0.88	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	23.83	1.25	1.00	0.17	0.33	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.10	1.87	0.00	0.47	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	103.19	4.17	1.30	2.45	0.72	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	49.72	2.29	0.76	1.27	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	59.61	5.45	0.75	0.75	1.50	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	34.38	3.07	2.10	0.28	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	43.99	4.36	0.59	0.34	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	35.71	4.76	0.48	1.43	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	82.45	4.40	1.47	1.96	1.22	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	49.05	1.55	0.44	1.33	0.66	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.90	2.63	0.00	0.59	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	27.79	0.58	0.39	0.78	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	23.27	1.32	0.00	1.32	0.26	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.81	0.00	0.37	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	27.67	0.36	0.00	0.36	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	29.81	0.85	0.00	1.14	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	27.18	1.58	0.79	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	15.74	0.00	0.00	0.00	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	30.75	0.00	0.00	0.80	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	26.75	1.67	0.00	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	31.63	1.38	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	35.52	1.85	0.34	0.67	0.17	0.67
Synoviocyte, donor2	11368-117I9	23.30	1.17	0.00	0.00	0.67	0.34
Synoviocyte, donor3	11440-118H9	26.14	1.12	0.00	1.12	0.45	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	52.53	4.65	2.14	0.71	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	41.62	1.98	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	53.02	2.08	1.62	0.93	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	26.67	1.58	1.00	0.14	0.00	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	29.77	1.55	1.55	0.39	0.77	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	33.21	0.00	0.57	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.79	1.97	0.74	0.49	0.49	0.25
Urethra, donor2	10319-105A4	68.34	5.40	1.80	1.80	1.80	3.60
Urothelial Cells, donor1	11520-119H8	74.12	2.13	1.59	1.86	0.80	0.27
Urothelial Cells, donor2	11600-120H7	41.26	0.80	1.20	0.80	0.00	0.40
Urothelial Cells, donor3	11681-122H7	50.65	3.21	0.92	0.46	0.69	0.23
Urothelial cells, donor0	11216-116B1	65.31	4.68	1.78	0.22	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	157.49	13.35	12.46	0.00	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	191.57	7.15	14.30	1.43	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	126.64	15.06	10.95	0.68	1.37	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	162.18	12.74	10.67	0.69	1.38	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	162.69	5.81	13.94	1.16	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	165.56	12.49	15.62	1.04	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	137.67	17.44	14.68	1.84	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	128.72	14.61	7.30	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	40.46	1.11	0.99	0.49	0.74	0.49
Wilms' tumor cell line:HFWT	10597-108E3	53.68	3.52	3.52	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	46.09	2.23	1.96	0.28	0.84	0.00
achilles tendon, donor2	10292-104G4	37.20	2.07	2.07	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	11.47	0.25	1.02	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	25.77	2.09	1.39	0.23	0.00	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	21.96	3.32	2.14	0.36	0.00	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	24.22	1.63	1.36	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	18.27	2.53	1.41	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	18.61	0.63	1.27	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	13.34	2.18	1.09	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	39.22	2.64	2.20	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	32.67	3.27	1.23	1.23	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	50.48	5.82	6.60	1.55	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.55	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	0.00	3.90	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	38.58	3.49	0.70	0.46	0.70	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.94	0.52	1.29	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	28.06	1.46	1.75	0.29	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	20.91	1.86	0.93	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	28.79	0.41	1.23	0.41	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	16.27	2.15	2.15	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	10.67	1.28	0.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	13.04	0.91	1.52	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	14.68	1.68	1.44	0.00	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.57	0.89	0.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	33.35	2.33	2.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	18.08	1.51	0.38	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	29.66	3.49	4.80	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	71.23	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.02	0.94	0.47	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	42.97	4.50	2.02	0.62	0.62	0.47
adipose, donor1	10184-103D4	25.80	6.45	6.45	0.00	0.59	0.00
adipose, donor2	10185-103D5	88.81	7.70	4.06	1.22	4.06	2.43
adipose, donor3	10186-103D6	52.55	4.90	3.27	1.09	1.36	1.63
adipose, donor4	10187-103D7	26.00	4.33	3.47	0.00	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	49.56	2.05	3.95	0.16	0.47	0.00
adrenal gland, adult, pool1	10081-102A9	36.38	7.28	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	28.55	0.40	1.07	0.13	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.80	0.71	0.36	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	30.37	1.62	0.70	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	38.21	2.03	2.03	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	19.74	0.00	1.18	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	61.66	2.37	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	63.67	4.06	1.62	0.81	2.23	0.81
amygdala, newborn, donor10223	10360-105E9	52.61	2.26	1.29	2.26	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	55.01	1.53	0.38	0.38	0.25	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	29.56	2.65	1.32	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	44.09	3.67	0.33	0.67	0.33	0.00
aorta, adult, pool1	10052-101G7	59.23	5.30	1.37	1.77	1.37	0.78
appendix, adult	10189-103D9	119.15	6.99	4.66	2.72	2.33	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	22.36	0.69	1.03	0.00	0.00	0.34
artery, adult	10190-103E1	24.46	0.00	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	112.71	10.58	3.19	1.01	0.87	2.17
b cell line:RPMI1788	10427-106D4	35.54	4.76	4.01	0.30	0.15	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	52.71	1.94	0.55	1.39	1.11	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	43.36	2.98	2.08	0.69	0.20	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	16.74	0.50	0.50	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	5.59	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	55.41	3.15	1.09	0.76	0.65	1.41
blood, adult, pool1	10053-101G8	77.51	8.86	6.64	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	50.52	1.71	0.86	1.71	0.00	0.86
bone marrow, adult	10192-103E3	35.77	2.02	0.67	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	68.68	2.05	1.03	3.08	2.05	6.15
brain, adult, pool1	10012-101C3	52.23	2.23	1.11	1.67	1.11	1.34
brain, fetal, pool1	10085-102B4	243.10	8.01	2.67	0.00	8.01	2.67
breast carcinoma cell line:MCF7	10482-107A5	68.72	2.64	1.32	0.99	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	70.65	2.75	2.25	0.25	0.00	0.25
breast, adult, donor1	10080-102A8	48.61	3.16	3.16	1.26	1.89	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	23.88	0.76	0.51	0.00	0.25	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	42.05	1.24	0.62	0.31	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	13.81	1.61	1.38	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	43.09	1.69	1.45	0.24	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	28.68	0.47	0.47	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	26.47	2.52	0.77	0.22	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	11.73	0.32	0.00	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	28.48	0.80	0.53	0.80	0.53	0.53
caudate nucleus - adult, donor10196	10177-103C6	62.17	2.30	0.00	2.30	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	57.56	4.35	0.84	3.01	3.68	3.01
caudate nucleus, adult, donor10258	10379-105H1	72.59	1.53	0.00	3.82	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	47.98	2.20	0.37	1.10	0.00	1.83
cerebellum - adult, donor10196	10173-103C2	81.57	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	94.80	1.49	0.85	2.14	1.92	1.49
cerebellum, adult, pool1	10083-102B2	48.64	0.69	0.00	2.07	2.76	1.72
cerebellum, newborn, donor10223	10357-105E6	50.65	2.49	3.32	1.66	0.83	0.00
cerebral meninges, adult	10188-103D8	44.38	3.78	0.50	0.76	1.01	1.26
cerebrospinal fluid, donor2	10294-104G6	20.46	2.92	0.00	0.73	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	27.32	0.72	0.14	0.29	0.14	0.14
cervical cancer cell line:ME-180	10553-107I4	26.51	0.50	0.33	0.33	0.00	0.17
cervix, adult, pool1	10013-101C4	58.48	2.73	1.68	0.94	0.63	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	41.52	0.70	0.14	0.42	0.70	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	35.27	1.31	1.31	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	27.71	0.50	0.75	0.00	0.12	0.12
choriocarcinoma cell line:SCH	10785-110H2	19.47	0.37	0.25	0.25	0.00	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	10.67	0.47	0.00	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	24.79	1.42	0.57	0.00	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	65.72	2.59	0.80	0.70	0.60	0.10
chorionic membrane cells, donor3	12240-129G8	17.58	1.10	1.10	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	12.12	2.02	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.74	4.61	2.50	0.38	0.58	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	52.16	2.53	0.63	0.63	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.37	0.26	0.00	0.26	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	22.49	0.24	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	17.51	0.61	0.41	0.41	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	23.26	0.00	0.00	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.26	5.21	2.87	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	34.29	2.06	1.60	0.23	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	35.92	2.26	1.04	0.17	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	38.99	2.93	1.65	0.37	0.37	0.37
colon carcinoma cell line:COLO-320	10420-106C6	21.28	0.76	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	49.98	2.38	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	41.24	2.70	0.82	0.24	1.18	0.12
colon, fetal, donor1	10070-101I7	40.17	1.85	1.24	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	320.85	22.92	9.17	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	54.39	6.80	4.25	0.85	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	38.19	9.36	1.06	0.30	0.60	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	32.01	6.91	0.99	1.13	0.28	0.42
corpus callosum, adult, pool1	10042-101F6	48.32	4.09	1.99	0.77	0.33	0.66
cruciate ligament, donor2	10295-104G7	51.87	0.00	1.62	3.24	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	42.54	0.00	1.61	0.80	0.80	0.00
diencephalon, adult	10193-103E4	32.64	1.92	0.48	0.48	0.72	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	14.01	1.61	2.07	0.23	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	48.72	1.28	1.54	0.51	0.26	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	29.13	3.13	0.72	0.24	0.24	0.24
ductus deferens, adult	10196-103E7	37.38	3.99	1.00	0.50	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	53.29	4.32	4.32	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	57.38	5.15	0.74	0.00	0.00	0.74
dura mater, adult, donor1	10041-101F5	55.91	2.56	1.57	0.83	0.50	1.40
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	20.87	1.55	2.89	0.00	0.67	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	26.22	2.29	2.44	0.86	0.14	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	22.81	0.62	1.23	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	40.56	0.91	0.91	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	35.20	0.31	0.31	0.00	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	31.52	2.63	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	36.54	2.68	0.67	1.01	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	35.70	1.99	0.36	0.36	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.27	0.48	0.00	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	27.57	1.89	1.22	0.11	0.33	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	72.04	5.06	3.19	0.22	0.11	0.22
epididymis, adult	10197-103E8	49.40	3.35	1.88	0.63	1.05	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	42.05	1.42	0.71	0.00	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.91	1.18	0.00	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	36.17	1.05	0.92	0.39	0.26	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	36.51	0.89	0.49	0.30	0.10	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	36.30	1.34	0.67	0.22	0.22	0.11
esophagus, adult, pool1	10015-101C6	51.18	1.59	1.49	0.42	0.96	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	46.84	1.63	0.63	0.25	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	36.22	0.00	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	32.74	1.49	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	37.83	2.29	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	71.41	2.91	0.00	2.91	0.00	2.91
eye, fetal, donor1	10054-101G9	50.08	1.27	1.02	0.25	0.00	2.80
fibrosarcoma cell line:HT-1080	10758-110E2	32.70	1.15	0.51	0.26	0.38	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.41	3.32	1.66	0.71	0.00	0.47
frontal lobe, adult, pool1	10040-101F4	63.14	3.00	0.56	1.13	0.94	1.31
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	28.82	1.20	1.20	0.60	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	50.38	1.92	1.74	0.09	0.18	0.37
gall bladder, adult	10198-103E9	51.18	5.07	1.45	1.45	0.97	2.41
gamma delta positive T cells, donor1	11937-126A2	118.11	8.05	3.76	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	137.07	5.98	2.61	0.75	1.87	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	25.35	1.90	0.84	0.21	0.00	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.47	1.55	0.19	0.19	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	30.66	0.16	1.15	0.00	0.00	0.33
gastric cancer cell line:GSS	10560-108A2	75.05	2.75	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	17.13	0.91	1.60	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	4.47	0.11	0.34	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	40.59	1.26	1.82	0.56	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	47.39	3.74	1.50	0.25	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	37.79	1.27	0.95	0.53	0.21	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	41.01	1.69	0.84	0.56	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	36.64	2.10	1.88	0.33	0.33	0.22
glioma cell line:GI-1	10413-106B8	36.61	1.46	1.46	0.00	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	48.84	0.73	0.73	0.00	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	50.28	5.61	1.46	0.98	1.46	1.22
globus pallidus, adult, donor10258	10367-105F7	38.34	1.37	2.74	2.74	1.37	5.48
globus pallidus, newborn, donor10223	10364-105F4	50.09	3.20	0.00	3.20	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	171.30	9.79	2.45	4.89	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	151.68	5.12	2.24	2.24	1.92	0.96
hIPS +CCl2, biol_rep1	14383-156B9	22.04	1.38	0.46	0.00	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	14.63	0.46	2.29	0.46	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	19.97	1.93	1.29	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	21.56	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	20.58	0.00	2.06	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	52.97	4.41	1.10	2.21	0.00	4.41
hairy cell leukemia cell line:Mo	10712-109I1	19.25	2.87	0.57	0.29	0.29	0.00
heart - mitral valve, adult	10205-103F7	50.82	2.69	1.79	0.90	2.09	1.20
heart - pulmonic valve, adult	10206-103F8	44.97	3.40	1.31	0.52	1.31	0.78
heart - tricuspid valve, adult	10207-103F9	59.12	7.49	0.83	0.83	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	43.06	2.45	1.02	0.82	0.82	1.22
heart, adult, diseased, donor1	10051-101G6	64.30	2.13	1.70	1.70	1.70	3.41
heart, adult, pool1	10016-101C7	53.35	2.30	0.23	1.15	0.69	0.46
heart, fetal, pool1	10046-101G1	87.28	5.44	1.75	1.95	0.51	3.59
hepatic mesenchymal tumor cell line:LI90	10778-110G4	106.13	5.24	0.62	3.09	2.16	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	14.27	1.19	1.19	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	20.77	1.66	0.77	0.22	0.22	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	20.63	1.70	0.97	0.00	0.36	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	25.26	2.12	1.62	0.40	0.30	0.20
hepatoma cell line:Li-7	10484-107A7	19.35	0.78	0.11	0.00	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	7.74	1.41	0.50	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	45.42	4.73	0.00	1.89	2.84	1.89
hippocampus, adult, donor10252	10153-102I9	55.11	3.06	1.02	1.84	2.86	1.43
hippocampus, adult, donor10258	10374-105G5	43.32	1.99	1.00	1.99	0.00	1.49
hippocampus, newborn, donor10223	10363-105F3	72.96	3.88	0.70	4.93	1.41	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6.71	0.61	4.27	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	12.37	0.98	1.37	0.00	0.20	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.01	2.54	2.29	0.00	0.00	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	26.50	2.26	2.82	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	25.05	3.10	1.55	0.26	0.26	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	22.02	2.28	0.76	0.38	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	40.58	2.04	1.75	0.88	0.29	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.90	2.59	1.72	0.86	0.43	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.05	3.75	2.50	0.42	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	29.13	2.60	0.71	0.47	0.24	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	34.39	2.09	1.29	0.32	0.48	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	40.40	1.35	2.02	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.34	2.97	1.88	0.16	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	9.33	1.97	0.98	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.11	0.87	0.00	0.00	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	61.86	6.68	5.15	0.57	1.15	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	58.00	9.59	4.36	0.87	1.74	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	52.47	10.49	5.00	1.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	61.42	6.41	2.83	1.88	0.75	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	58.66	3.64	2.27	1.36	2.27	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	61.71	6.89	1.88	1.25	0.00	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	49.32	2.29	1.47	0.98	0.65	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	53.13	2.32	1.45	1.74	0.58	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	57.69	3.89	1.49	1.49	0.90	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.04	3.69	2.03	0.18	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	18.26	3.14	3.71	0.00	0.00	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	11.02	2.04	3.27	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	56.33	5.63	3.17	1.41	1.41	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	47.51	6.02	5.70	0.63	0.95	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	47.51	9.08	3.03	0.91	0.30	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	56.37	5.17	1.03	2.07	1.55	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	69.07	3.32	1.99	1.99	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	38.48	2.82	2.82	2.31	0.00	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	36.56	2.56	1.53	1.53	1.53	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	50.73	2.27	2.27	0.76	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	48.39	3.36	1.01	1.01	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	18.60	3.38	2.66	0.24	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	10.70	1.34	2.23	0.00	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	17.56	2.44	1.46	0.49	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	33.31	7.95	3.06	1.22	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	3.25	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	20.19	2.65	1.99	0.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	33.93	3.83	2.74	2.19	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	34.02	3.62	1.81	0.72	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	33.10	1.78	1.78	1.07	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	4.77	1.19	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	35.08	2.98	3.11	0.81	1.35	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	24.78	1.62	1.35	0.27	0.00	0.27
immature langerhans cells, donor1	11904-125F5	18.89	0.97	0.24	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	15.05	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	70.88	4.26	0.76	1.80	2.37	2.74
keratoacanthoma cell line:HKA-1	10791-110H8	21.13	0.65	0.00	0.00	0.65	0.00
kidney, adult, pool1	10017-101C8	39.25	2.90	0.70	0.40	0.30	0.20
kidney, fetal, pool1	10045-101F9	49.59	2.76	1.63	0.99	0.57	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	145.71	3.27	3.55	1.14	0.57	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.90	0.41	0.00	0.14	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	71.38	2.39	1.10	0.37	0.55	0.73
left atrium, adult, donor1	10079-102A7	64.29	4.36	1.63	1.09	2.18	2.72
left ventricle, adult, donor1	10078-102A6	41.46	3.54	0.51	0.51	1.52	1.01
leiomyoblastoma cell line:G-402	10721-110A1	48.16	3.01	0.82	0.27	0.55	0.82
leiomyoma cell line:10964C	10569-108B2	22.63	0.36	0.36	1.08	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	27.17	0.54	0.00	0.54	0.54	0.54
leiomyoma cell line:15425	10571-108B4	23.80	0.73	0.00	0.00	0.49	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	59.60	1.05	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	13.93	1.42	0.71	0.00	0.00	0.12
liposarcoma cell line:KMLS-1	10782-110G8	30.15	0.78	0.47	0.78	0.31	0.47
liposarcoma cell line:SW 872	10726-110A6	56.05	2.31	0.97	1.22	0.73	0.37
liver, adult, pool1	10018-101C9	15.07	1.78	0.81	0.00	0.32	0.00
liver, fetal, pool1	10086-102B5	13.17	1.88	1.88	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	40.10	1.46	1.02	1.46	0.44	1.17
locus coeruleus, adult, donor10252	10165-103B3	45.58	2.95	1.85	0.74	1.29	0.92
locus coeruleus, adult, donor10258	10375-105G6	41.19	2.54	1.13	1.41	1.69	0.85
locus coeruleus, newborn, donor10223	10362-105F2	22.29	2.10	1.68	1.26	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	23.11	0.42	0.69	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	68.25	6.89	2.76	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	74.74	4.75	1.71	0.66	0.13	0.13
lung, adult, pool1	10019-101D1	51.86	4.02	1.54	1.06	0.47	0.47
lung, fetal, donor1	10068-101I5	63.08	4.85	2.57	0.86	0.57	0.57
lung, right lower lobe, adult, donor1	10075-102A3	66.44	5.04	3.21	1.37	2.75	0.00
lymph node, adult, donor1	10077-102A5	89.47	8.99	0.95	2.84	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	44.05	4.38	2.41	0.22	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	27.02	3.62	1.96	0.15	0.45	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	53.52	0.00	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	63.05	1.78	0.44	3.11	1.78	0.89
mature adipocyte, donor2	12232-129F9	59.35	4.98	1.25	3.74	1.45	1.04
mature adipocyte, donor3	12233-129G1	50.02	4.27	1.42	1.66	0.71	1.42
mature adipocyte, donor4	12234-129G2	35.80	1.32	0.53	0.53	0.53	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	37.64	0.95	1.19	0.48	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	43.99	4.51	0.00	1.13	1.13	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	59.77	4.05	0.74	1.29	2.21	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	49.88	2.22	0.00	1.27	0.32	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	28.15	0.85	0.00	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	54.17	2.03	0.68	1.18	1.69	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	65.37	3.40	1.27	1.70	2.55	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	53.94	3.85	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	75.02	4.31	0.72	2.15	0.36	2.15
medulla oblongata - adult, donor10196	10174-103C3	33.75	3.89	0.65	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	44.89	3.87	2.32	1.24	0.77	0.62
medulla oblongata, adult, pool1	10038-101F2	46.45	2.78	1.31	0.90	0.82	1.06
medulla oblongata, newborn, donor10223	10361-105F1	30.90	1.74	0.35	1.74	0.00	1.39
medulloblastoma cell line:D283 Med	10838-111E1	70.85	3.99	1.11	0.00	0.00	0.44
medulloblastoma cell line:ONS-76	10759-110E3	31.42	1.35	0.49	0.24	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	18.40	1.58	1.15	0.43	0.43	0.14
melanoma cell line:G-361	10465-106H6	36.10	3.26	0.54	0.81	0.54	1.09
meningioma cell line:HKBMM	10691-109F7	36.36	3.62	2.53	0.72	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	49.34	0.00	0.88	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	17.89	0.26	0.26	0.00	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.33	1.99	0.77	0.77	0.31	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.45	2.18	0.91	0.55	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	14.49	1.66	0.83	0.41	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	23.18	0.84	0.14	0.42	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.49	1.16	0.00	0.00	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	16.66	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	16.82	0.69	0.34	0.17	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	22.20	1.84	0.69	0.23	0.35	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	26.13	1.19	0.13	0.80	0.53	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	19.18	1.76	0.68	0.68	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	42.39	2.42	0.28	0.57	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.49	1.98	0.33	0.33	0.33	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	37.36	1.52	0.14	0.83	0.55	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	32.81	1.40	0.00	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	33.69	2.25	0.41	0.41	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	26.96	4.31	1.08	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	38.28	0.93	0.21	0.21	0.83	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	25.08	0.68	0.23	0.68	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	33.15	1.68	0.42	0.00	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.52	2.84	0.75	0.45	0.75	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.43	1.66	0.44	0.26	0.00	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	60.38	2.58	0.74	0.37	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	50.65	3.43	1.14	1.43	0.86	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	33.68	2.11	0.42	0.42	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	27.86	1.83	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.62	1.02	0.00	0.51	0.51	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	29.58	1.05	1.05	0.79	0.52	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	32.66	0.92	0.31	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.36	1.88	0.47	0.71	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	26.06	1.69	0.34	1.02	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	33.80	1.18	1.96	0.79	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	31.51	0.93	0.46	0.46	1.39	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	42.69	1.73	0.29	0.00	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	32.35	2.23	0.22	1.56	0.45	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	35.33	0.96	0.48	0.48	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	60.87	2.20	0.00	0.00	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	28.53	0.34	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	38.07	0.82	0.41	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	29.21	0.86	0.86	0.00	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	41.02	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	33.45	0.97	0.32	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	33.46	1.45	0.00	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	52.77	2.13	0.00	0.53	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	37.62	0.82	0.00	2.45	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	36.93	0.78	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	32.78	0.99	0.99	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	41.51	1.78	0.59	1.78	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	31.68	2.44	0.00	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	43.70	3.80	0.63	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	31.39	0.69	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.56	1.22	0.00	1.22	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.09	0.79	0.00	0.79	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	0.59	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.08	0.62	0.31	1.25	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	21.29	0.00	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.72	0.69	0.00	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.82	0.00	0.99	0.49	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	24.67	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	22.90	0.64	0.00	0.64	0.64	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	20.15	0.81	0.00	0.40	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	1.27	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.81	0.00	0.00	1.21	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.01	0.82	0.00	0.00	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	26.59	0.79	0.60	0.79	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	23.69	1.62	0.32	0.65	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	1.02	1.02	1.02	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	88.20	3.87	2.32	0.00	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	88.83	1.42	1.42	0.71	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	50.97	2.55	0.93	0.93	0.46	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.52	1.03	0.31	0.10	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	83.97	6.58	2.27	0.68	0.45	0.68
mesothelioma cell line:Mero-41	10851-111F5	60.14	3.42	1.22	0.24	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	60.01	1.77	1.11	0.66	0.44	0.66
mesothelioma cell line:Mero-82	10853-111F7	58.61	2.89	0.79	1.05	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	60.43	1.53	0.85	0.17	0.34	0.34
mesothelioma cell line:Mero-84	10855-111F9	63.19	13.14	2.02	0.00	0.00	0.76
mesothelioma cell line:Mero-95	10856-111G1	42.86	1.45	1.04	0.41	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	74.04	2.65	1.99	0.66	0.17	0.50
mesothelioma cell line:NCI-H226	10846-111E9	59.37	1.09	0.18	0.54	0.72	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	58.25	1.88	0.51	0.34	0.17	0.34
mesothelioma cell line:NCI-H28	10845-111E8	11.71	0.76	0.51	0.25	0.25	0.00
mesothelioma cell line:No36	10857-111G2	25.77	0.98	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	39.29	1.90	0.54	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	42.61	1.34	0.96	0.19	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	57.88	1.47	1.10	0.49	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	64.07	2.51	1.08	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	39.50	2.94	1.63	0.33	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	31.15	1.27	1.06	0.21	0.00	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	32.02	1.38	1.15	0.46	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	48.14	6.47	0.57	0.76	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	13.67	1.48	1.29	0.00	0.18	0.18
myeloma cell line:PCM6	10474-106I6	15.22	0.20	1.19	0.20	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	46.67	3.04	0.51	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	71.79	1.37	0.78	2.94	1.96	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.47	0.78	0.22	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.06	0.22	0.22	0.22	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	26.50	3.86	0.55	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	14.49	0.23	0.00	0.23	0.23	0.46
neuroblastoma cell line:NB-1	10539-107G8	25.44	2.81	1.87	0.75	0.19	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	28.26	0.63	0.84	0.42	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	40.25	1.30	0.56	0.93	0.19	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	80.42	1.90	3.08	0.47	2.14	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	24.71	1.58	0.16	0.48	0.79	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	29.38	1.01	0.81	0.20	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	54.68	1.91	1.27	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	69.47	1.60	0.27	1.86	0.80	2.40
neutrophil PMN, donor1	12133-128D9	461.12	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	48.20	12.35	4.40	0.51	0.17	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.01	0.80	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	43.28	1.92	0.32	0.32	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	26.28	1.84	0.53	1.05	0.53	0.79
nucleus accumbens, adult, pool1	10037-101F1	62.15	2.62	1.31	2.44	2.62	2.25
occipital cortex - adult, donor10196	10172-103C1	41.21	0.00	0.00	2.06	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	77.29	5.37	2.42	1.61	3.22	1.34
occipital cortex, newborn, donor10223	10355-105E4	74.24	3.64	0.73	0.73	0.36	2.55
occipital lobe, adult, donor1	10076-102A4	61.14	2.36	0.26	2.89	2.62	4.20
occipital lobe, fetal, donor1	10073-102A1	222.70	6.87	0.86	1.29	7.29	2.15
occipital pole, adult, pool1	10036-101E9	63.55	3.23	0.55	1.50	1.58	3.23
olfactory region, adult	10195-103E6	54.26	2.48	0.57	1.15	1.53	1.91
optic nerve, donor1	10277-104E7	46.02	2.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	41.46	1.37	1.59	0.46	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	56.05	1.51	1.10	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	37.08	2.03	1.02	0.34	0.51	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	46.20	4.97	2.31	0.46	0.46	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	59.68	2.65	1.47	0.00	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	85.96	12.15	2.80	2.80	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	22.90	0.64	0.64	0.42	0.64	0.64
ovary, adult, pool1	10020-101D2	69.18	3.32	0.79	0.87	0.79	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.21	2.38	0.55	0.73	0.55	0.00
pancreas, adult, donor1	10049-101G4	27.28	3.76	0.00	0.94	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	16.77	0.84	0.28	0.28	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	50.94	3.07	1.02	0.34	0.00	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	32.62	1.66	1.16	0.17	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	60.59	2.56	0.46	0.82	2.20	2.11
parietal cortex, adult, donor10258	10373-105G4	44.04	5.14	0.00	0.00	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	44.20	0.94	0.00	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	64.13	2.28	2.57	1.71	1.71	0.57
parietal lobe, adult, pool1	10034-101E7	56.66	3.52	0.44	2.03	1.23	1.41
parietal lobe, fetal, donor1	10072-101I9	192.03	2.91	0.97	1.94	6.79	0.97
parietal lobe, newborn, donor10223	10356-105E5	52.71	2.99	1.12	2.99	1.50	1.12
parotid gland, adult	10199-103F1	132.58	12.95	1.85	1.23	0.62	0.62
penis, adult	10200-103F2	39.75	1.61	2.15	2.15	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	40.72	1.30	0.19	0.37	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	129.09	8.74	4.52	1.60	0.73	1.17
pineal gland - adult, donor10196	10179-103C8	83.85	6.45	1.29	7.74	1.29	5.81
pineal gland, adult, donor10252	10160-103A7	83.50	6.51	2.37	7.11	5.92	4.15
pineal gland, adult, donor10258	10377-105G8	54.56	5.02	1.88	5.02	1.88	1.88
pituitary gland - adult, donor10196	10180-103C9	51.60	0.00	0.00	2.02	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	95.90	4.17	4.17	1.04	3.13	0.00
pituitary gland, adult, donor10258	10378-105G9	46.82	0.85	0.00	4.26	0.00	0.00
placenta, adult, pool1	10021-101D3	35.80	1.72	0.43	0.22	0.75	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	30.59	4.37	1.59	0.13	0.26	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	26.93	2.02	0.47	0.62	0.00	0.16
pons, adult, pool1	10033-101E6	33.48	1.89	0.86	1.12	0.69	1.55
postcentral gyrus, adult, pool1	10032-101E5	55.79	1.57	0.61	1.13	1.57	2.53
promyelocytes/myelocytes PMC, donor1	12132-128D8	79.47	4.18	6.27	2.09	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	42.39	2.33	1.89	0.29	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	50.28	0.73	0.73	0.00	0.18	0.18
prostate, adult, pool1	10022-101D4	60.94	3.17	2.27	1.18	0.63	1.00
putamen, adult, donor10196	10176-103C5	70.35	4.01	1.89	2.12	2.36	2.36
putamen, adult, donor10252	10152-102I8	137.25	3.92	1.96	7.84	5.88	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	2.19	0.00	0.00	1.09	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	59.44	3.62	0.48	4.59	1.69	2.66
putamen, newborn, donor10223	10365-105F5	14.99	2.25	0.00	3.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	43.06	1.45	0.29	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	69.55	2.78	4.17	4.17	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	37.31	1.48	1.48	0.21	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.14	0.83	0.83	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	67.19	2.78	1.79	1.59	1.59	2.09
retinoblastoma cell line:Y79	10475-106I7	21.82	0.26	1.04	0.00	0.52	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.55	1.11	1.11	0.00	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	60.46	1.41	2.25	1.12	0.28	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	46.99	0.76	0.76	1.52	0.76	0.76
salivary acinar cells, donor1	11771-123I7	18.45	2.91	0.32	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	18.45	1.51	0.14	0.00	0.00	0.14
salivary acinar cells, donor3	11773-123I9	30.45	0.66	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	164.15	5.72	5.15	1.72	2.86	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	32.29	1.26	1.18	0.76	0.08	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	32.33	1.29	0.47	0.71	0.12	0.00
seminal vesicle, adult	10201-103F3	41.80	2.12	1.06	0.53	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	36.44	2.67	0.97	0.00	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	31.71	3.52	1.51	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	42.15	4.01	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.52	0.67	0.67	0.13	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	16.58	0.11	0.11	0.33	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	11.61	1.03	1.03	0.13	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	13.48	0.00	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	25.19	1.20	0.84	0.12	0.48	0.24
skeletal muscle, fetal, donor1	10066-101I3	63.32	5.03	3.02	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	35.98	0.00	0.63	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	31.35	2.33	0.33	1.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	33.10	2.21	1.26	0.95	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	88.09	1.16	1.93	0.19	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	18.30	0.66	0.16	0.16	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	28.63	2.25	0.97	0.48	0.16	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	40.31	3.05	1.53	1.74	1.09	1.09
small intestine, adult, pool1	10024-101D6	28.19	1.91	1.43	0.60	0.48	0.60
small intestine, fetal, donor1	10064-101I1	25.80	0.49	0.25	0.49	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	25.13	2.56	1.03	0.00	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	55.83	3.62	0.78	0.52	1.81	1.55
somatostatinoma cell line:QGP-1	10781-110G7	31.36	1.61	1.34	0.27	0.00	0.80
spinal cord - adult, donor10196	10181-103D1	41.75	2.52	0.23	1.15	0.69	0.69
spinal cord, adult, donor10252	10159-103A6	46.92	4.34	1.58	0.00	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	24.21	2.08	1.38	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	92.09	2.44	1.22	1.83	1.83	1.83
spinal cord, newborn, donor10223	10359-105E8	16.99	2.30	0.46	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	64.82	6.12	2.09	1.64	1.05	1.05
spleen, adult, pool1	10025-101D7	60.79	3.96	3.30	0.22	0.55	0.11
spleen, fetal, pool1	10044-101F8	64.84	7.63	4.29	0.72	0.79	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	21.63	0.52	0.93	0.21	0.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	31.52	1.14	0.95	0.19	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	30.75	1.05	1.05	0.70	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	51.60	1.17	1.17	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	30.50	1.01	0.34	0.11	0.11	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	27.53	2.54	1.27	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	83.34	4.23	2.54	1.69	0.85	0.85
stomach, fetal, donor1	10062-101H8	64.08	0.00	1.07	0.00	0.00	4.27
submaxillary gland, adult	10202-103F4	162.36	8.55	5.70	0.00	0.00	3.99
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	40.71	2.91	1.45	0.42	0.42	0.42
substantia nigra, adult, donor10258	10371-105G2	42.41	2.07	1.03	1.03	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	44.51	3.53	0.71	1.41	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	50.67	1.38	1.60	0.00	0.92	0.46
temporal lobe, adult, pool1	10031-101E4	67.14	3.05	1.19	2.03	2.03	1.70
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	170.94	1.42	1.42	0.71	5.70	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	150.76	6.15	0.88	1.32	2.64	0.44
tenocyte, donor1	11763-123H8	42.59	1.75	0.00	0.35	0.70	0.35
tenocyte, donor2	11765-123I1	25.94	1.14	0.00	0.76	0.76	0.00
tenocyte, donor3	11768-123I4	35.95	1.48	0.74	1.11	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	9.35	1.36	0.68	0.00	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	29.90	2.77	1.39	0.31	0.77	0.31
teratocarcinoma cell line:PA-1	10807-111A6	19.22	1.70	2.32	0.31	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	9.39	1.27	0.25	0.38	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.88	1.13	1.51	0.00	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	0.11	0.11	0.11	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	15.63	1.30	3.58	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	104.47	3.01	1.50	2.58	2.15	3.76
testis, adult, pool2	10096-102C6	130.36	2.26	0.90	3.16	4.06	4.06
thalamus - adult, donor10196	10168-103B6	41.95	3.31	1.10	0.00	2.21	1.10
thalamus, adult, donor10252	10154-103A1	48.76	4.84	1.56	1.41	0.94	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	38.49	1.54	1.54	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	40.51	2.47	0.33	1.98	0.99	0.99
thalamus, newborn, donor10223	10366-105F6	20.14	1.15	0.58	2.30	0.58	0.58
throat, adult	10209-103G2	44.44	2.25	1.75	0.75	0.50	1.25
throat, fetal, donor1	10061-101H7	53.93	1.52	1.22	1.83	1.52	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	30.60	0.20	0.20	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	92.36	5.17	3.78	1.09	0.70	0.20
thymus, fetal, pool1	10043-101F7	97.05	6.44	5.20	0.73	1.56	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	39.09	0.93	0.66	0.13	0.27	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	64.96	2.65	0.98	0.28	0.84	0.42
thyroid, adult, pool1	10028-101E1	60.37	2.80	1.68	0.93	1.03	0.93
thyroid, fetal, donor1	10060-101H6	69.08	3.95	2.37	2.11	0.26	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	38.14	2.79	0.47	0.00	0.70	1.16
tongue, fetal, donor1	10059-101H5	25.62	0.79	0.79	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	107.99	6.41	6.01	1.40	1.00	0.60
trachea, adult, pool1	10029-101E2	60.45	3.52	2.04	0.65	0.33	0.33
trachea, fetal, donor1	10058-101H4	65.78	3.08	0.77	1.15	1.92	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	30.47	2.83	1.06	1.06	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	29.28	1.22	1.42	0.10	0.20	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	48.10	2.98	1.72	0.78	0.31	0.16
tridermal teratoma cell line:HGRT	10694-109G1	43.76	1.90	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	41.14	2.71	1.52	0.34	0.17	0.25
umbilical cord, fetal, donor1	10057-101H3	47.99	4.17	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	52.21	2.56	2.05	1.19	0.68	0.85
uterus, fetal, donor1	10055-101H1	54.26	3.58	2.05	0.00	2.05	2.05
vagina, adult	10204-103F6	42.00	4.52	2.58	0.00	0.00	0.00
vein, adult	10191-103E2	84.83	4.60	3.73	1.53	1.97	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	43.79	4.27	1.07	0.80	0.27	0.53